WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Lung Cancer efficacy endpoints v2, Cystic lesion has_value >Simple >Complex, Non-measurable lesions has_subtype Non-target lesion, Objective Response Rate (ORR) measured by Tumor Size, Response criteria name (e,g, RANO, RECIST) classified into Progression, Lung Cancer Efficacy Endpoints include Progression free survival (PFS), Follow-up evaluation summarized_by Measurable lesions, Therapeutic Efficacy Endpoint is the intersection of Observation or Assessment, Objective Response Rate (ORR) ???? Tumor assessment, Anatomical region has_option Other, Follow-up evaluation summarized_by New lesions, Progression free survival (PFS) assesses Disease progression, Non-measurable lesions has_location Anatomical region, Non-target lesion can_include Cystic lesion, Baseline assessment has_pertinent_ information Imaging evaluation method, Disease progression validated_by Tumor assessment, Effusion/ascites has_value >Yes >No, Objective Response Rate (ORR) measured by Defined Time Points, Lung Cancer Efficacy Endpoints include Objective Response Rate (ORR), Non-target lesion has_component Qualitative assessment, Repeated concepts/instances throughout the CMAP are denoted by dotted outline